Research into the basic science of cancer immunology has enabled us to harness the power of the immune system to treat cancer.
We are now entering a golden age of immunotherapy where new, sophisticated and innovative treatments are providing unprecedented cures for patients with advanced cancers. Chimeric antigen receptor (CAR) T cells are genetically engineered immune cells that can seek out and destroy cancer cells. So far, results have been very promising, but the use of CAR-T cells is associated with frequent, serious short-term toxicities.
The 13th of March 2020, I have completed the course on Chimeric antigen receptor (CAR) T cells and earned the enclosed certificate.
I have conducted the course from the -Leukaemia Care organisation-, because I am interested
in finding new treatment alternatives and believe CAR-T cell treatment will be or is already
the "next generation" treatment.
The course gives an overview of the field of CAR-T cells development, treatment and includes four (4) chapters.
- Chapter 1: Introduction to CAR-T
- Chapter 2: Clinical Application of CAR-T cells
- Chapter 3: Practical Aspects of CAR-T
- Chapter 4: Future Directions of CAR-T